Oral Covid vaccine developer nails down Peninsula space

With its oral vaccines for Covid-19 and norovirus heading into mid-stage clinical trials, Vaxart Inc. will add nearly 25,000 square feet in South San Francisco as it hires more people. The company (NASDAQ: VXRT) inked a lease for 24,544 square feet at 310 Utah Ave. — space being vacated by Sutro Biopharma Inc. as it moves into the former Five Prime Therapeutics headquarters at The Cove development off Oyster Point Boulevard in South San Francisco. Vaxart also will rent 24,606 square feet at 170…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news